Held on 04 January 2017
Bafna Pharmaceuticals announced that meeting of the Board of Directors of the Company was held on 04 January 2017, where it was decided to withdraw entire preferential issue of 40,00,000 share warrants and in-principle application filed with the Stock Exchanges.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content